Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 930-964-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Monochloroacetic acid: Oral repeated dose toxicity: key studies: data obtained from exposure during 16 days, 13 weeks and 2 years both in rats and mice (FDA regulations).
Monochloroacetic acid: Inhalation repeated dose toxicity: supporting information: data obtained from exposure during 4 months in rats and guinea pigs (no guideline was followed).
Methyl chloroacetate: Inhalation repeated dose toxicity: Key study: 28-day inhalation study conducted according to OECD guideline 412.
Key value for chemical safety assessment
Additional information
Reaction mass of methyl chloroacetate and chloroacetic acid:
1.- Chloroacetic acid: Oral repeated-dose toxicity studies with 16-day and 13-week exposure to monochloroacetic acid were available. Within the limited study design of the 16-day toxicity studies (by gavage), the NOAEL in rats was 60 mg/kg bw/day for males and equal or greater than 120 mg/kg bw/day for females, and in mice 120 mg/kg bw/day, both based on mortality. A NOAEL could not be derived from the results of 13-week repeated-dose toxicity study with rats (by gavage). Changes in the weight of the heart, liver, kidneys, and clinical chemistry values were observed at the lowest dose level tested, i.e., 30 mg/kg bw/day. Dose-related cardiomyopathy was found in both sexes at 60 mg/kg bw/day and above. An increased liver weight and decreased serum cholinesterase activity were observed in mice exposed during 13-weeks by gavage, the NOAEL was 100 mg/kg bw/day.
A NOAEL of 3.5 mg/kg bw/day is also derived from the 2-year drinking water study performed by DeAngelo et al. (1997) in rats. At this level, no effect on survival, body weight, or (non-) neoplastic lesions was found.
Main target organs of monochloroacetic acid after prolonged oral administration are liver in both rats and mice, and heart and kidneys in rats. Additionally, growth depression, decreased survival, and inflammation of the nasal mucosa were observed in the carcinogenicity studies. The effects on the heart disappeared at lower dose levels in repeated-dose toxicity studies with longer study duration. Based on the data available, rats appeared to be more sensitive for the toxic effects of monochloroacetic acid than mice.
The repeated dose inhalation toxicity of monochloroacetic acid was studied experimentally on white rats and guinea pigs for 4 months. The tested dose for rats was 20.8 ( ± 1.0) mg/m3. Chronic inhalation of monochloroacetic acid caused reduction of weight in rats (after 10 weeks of exposure), diminished oxygen uptake (on the 3rd and 15th days of exposure), lowering of rectal temperature (at 2nd and 15th days), reduction of the chloride content in urine (after 2 months of exposure), hemoglobinemia (after 4 months) and inflammatory changes in the respiratory organs. The tested dose for guinea pigs was 5.8 ( ± 0.3) mg/m3. Chronic inhalation of monochloroacetic acid caused reduction of weight in guinea pigs (after 2 weeks of exposure), lowering of rectal temperature (at 2nd and 15 th days), reduction of the chloride content in urine (after 2 months of exposure), hemoglobinemia (after 4 months) and inflammatory changes in the respiratory organs.
2.- Methyl chloroacetate: 28-day inhalation study conducted according to OECD guideline 412. The effects observed were clinical signs, retardation of the body weight development and changes in lung weight with no evidence of organ dysfunction.
These effects are considered not to support classification for specific target organ toxicity following repeated exposure.
Justification for classification or non-classification
Based on the results from the repeated dose toxicity studies, neither the substance chloroacetic acid nor the substance methyl chloroacetate are classified. Therefore, the reaction mass of chloroacetic acid and methyl chloroacetate is not classified for repeated dose toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.